Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Public Health
Email alerts
Public Health
Sub-lethal ionizing radiation alters Foxp3 expression in CD4+ T regulatory (Treg) cells in vitro and in vivo
Anita
Kumari
,
Samantha
Simon
,
Charlie
Garnett-Benson
Journal for ImmunoTherapy of Cancer
Dec 2015,
3
(Suppl 2)
P269;
DOI:
10.1186/2051-1426-3-S2-P269
Expression of tumor-associated carbohydrate antigen Tn in cancer cells is stimulated by cytokine secreted from cancer cells
Alex
Lin
,
Chiao-en
Chen
,
Jaulang
Hwang
Journal for ImmunoTherapy of Cancer
Dec 2014,
2
(Suppl 3)
P170;
DOI:
10.1186/2051-1426-2-S3-P170
Cish attenuates proximal TCR-signaling and CD8+ T cell immunity
Douglas
Palmer
,
Geoffery
Guittard
,
Shashank
Patel
,
Lawrence E
Samelson
,
Nicholas P
Restifo
Journal for ImmunoTherapy of Cancer
Dec 2014,
2
(Suppl 3)
P32;
DOI:
10.1186/2051-1426-2-S3-P32
Immunotherapy targeting esophageal cancer stem cells
Dongli
Yue
,
Hongzheng
Ren
,
Lan
Huang
,
Yi
Zhang
Journal for ImmunoTherapy of Cancer
Nov 2013,
1
(Suppl 1)
P178;
DOI:
10.1186/2051-1426-1-S1-P178
P25. Access to diagnostics: a bottleneck for immunotherapeutics development - case example of MAGE-A3 cancer immunotherapeutic
K
Lykopoulos
,
P
Collins
,
M
Hall
,
R
Ehness
,
J
Barth
,
J
Louahed
Journal for ImmunoTherapy of Cancer
Mar 2014,
2
(Suppl 2)
P16;
DOI:
10.1186/2051-1426-2-S2-P16
P65. Minor-histocompatibility-antigen UTY as target for graft-versus-leukaemia and graft-versus-haematopoiesis in the canine-model
D
Bund
,
FG
Gökmen
,
J
Zorn
,
R
Buhmann
,
HJ
Kolb
,
H
Schmetzer
Journal for ImmunoTherapy of Cancer
Mar 2014,
2
(Suppl 2)
P39;
DOI:
10.1186/2051-1426-2-S2-P39
P19. Immunomodulation of blasts in AML-patients (pts) with clinically approved response modifiers to improve anti leukaemic T-cell reactivity: an ex vivo simulation of the clinical situation
H
Schmetzer
,
Z
Stankova
,
D
Deen
,
A
Hirn
,
Y
Vokac
,
T
Kroell
,
R
Buhmann
,
A
Hausmann
,
C
Schmid
,
J
Tischer
Journal for ImmunoTherapy of Cancer
Mar 2014,
2
(Suppl 2)
P10;
DOI:
10.1186/2051-1426-2-S2-P10
Pages
« first
‹ previous
1
2
Special collections
COVID-19
(44)
Editor's choice
JITC
Basic Tumor Immunology
(538)
Case Reports
(191)
Clinical Trials Monitor
(17)
Clinical/Translational Cancer Immunotherapy
(941)
Commentary/Editorials
(142)
Computational I-O
(4)
COVID-19 and Cancer Immunotherapy
(10)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(55)
Guidelines and Consensus Statements
(50)
Imaging and Immunotherapy
(8)
Immune Cell Therapies and Immune Cell Engineering
(213)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(407)
Liquid Biopsies
(9)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(143)
Reviews
(239)
Open access
(4871)
Press releases